文献
J-GLOBAL ID:201902289250144739
整理番号:19A1128803
肝細胞癌の進行を抑制するためのSLC46A3の発現増加とソラフェニブ療法に対するその効果【JST・京大機械翻訳】
Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy
著者 (37件):
Zhao Qing
(Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Zhao Qing
(Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China)
,
Zhao Qing
(Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China)
,
Zhao Qing
(National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Zheng Bo
(The International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, PR China)
,
Meng Shiquan
(The International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, PR China)
,
Xu Ying
(Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Xu Ying
(Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China)
,
Xu Ying
(Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China)
,
Xu Ying
(National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Guo Jing
(Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Guo Jing
(Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China)
,
Guo Jing
(Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China)
,
Guo Jing
(National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Chen Li-jie
(Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Chen Li-jie
(Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China)
,
Chen Li-jie
(Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China)
,
Chen Li-jie
(National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Xiao Jian
(National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Xiao Jian
(Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Zhang Wei
(Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Zhang Wei
(Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China)
,
Zhang Wei
(Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China)
,
Zhang Wei
(National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Tan Zhi-rong
(Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Tan Zhi-rong
(Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China)
,
Tan Zhi-rong
(Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China)
,
Tan Zhi-rong
(National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Tang Jie
(Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Tang Jie
(Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China)
,
Tang Jie
(Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China)
,
Tang Jie
(National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Chen Lei
(The International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, PR China)
,
Chen Yao
(Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
,
Chen Yao
(Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China)
,
Chen Yao
(Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China)
,
Chen Yao
(National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China)
資料名:
Biomedicine & Pharmacotherapy
(Biomedicine & Pharmacotherapy)
巻:
114
ページ:
Null
発行年:
2019年
JST資料番号:
A0845C
ISSN:
0753-3322
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)